RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers

被引：0

作者：

Emma Nolan

François Vaillant

Daniel Branstetter

Bhupinder Pal

Göknur Giner

Lachlan Whitehead

Sheau W Lok

Gregory B Mann

Kathy Rohrbach

Li-Ya Huang

Rosalia Soriano

Gordon K Smyth

William C Dougall

Jane E Visvader

Geoffrey J Lindeman

机构：

[1] Walter and Eliza Hall Institute of Medical Research (WEHI),ACRF Stem Cells and Cancer Division

[2] University of Melbourne,Department of Medical Biology

[3] Amgen Inc.,Department of Pathology

[4] Walter and Eliza Hall Institute of Medical Research,Bioinformatics Division

[5] Imaging Laboratory,Systems Biology and Personalized Medicine Division

[6] Walter and Eliza Hall Institute of Medical Research,Department of Medical Oncology

[7] Familial Cancer Centre,Department of Surgery

[8] Royal Melbourne Hospital,Department of Mathematics and Statistics

[9] Royal Melbourne Hospital,Department of Medicine

[10] The Breast Service,undefined

[11] Royal Melbourne Hospital and Royal Women's Hospital,undefined

[12] University of Melbourne,undefined

[13] University of Melbourne,undefined

[14] Therapeutic Innovation Unit,undefined

[15] Amgen Inc.,undefined

[16] University of Melbourne,undefined

[17] Familial Cancer Centre,undefined

[18] Victorian Comprehensive Cancer Centre,undefined

[19] Present addresses: Cynosure Clinical Research LLC,undefined

[20] North Bend,undefined

[21] Washington,undefined

[22] USA (D.B.); Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute,undefined

[23] Herston,undefined

[24] Queensland,undefined

[25] Australia (W.C.D.).,undefined

来源：

Nature Medicine | 2016年 / 22卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

A new study by Jane Visvader, Geoff Lindeman and colleagues reports on the potential role of RANK signaling in pre-neoplastic breast tissue from BRCA1-mutation carriers and in a mouse model of Brca1-deficient mammary cancer, suggesting that targeting RANK could be explored as an approach to prevent growth of tumors harboring mutated BRCA1.

引用

页码：933 / 939

页数：6

共 50 条

[41] Aspirin and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Kornhauser, Naomi
Terry, Mary Beth
Vahdat, Linda T.
Andrulis, Irene
Buys, Saundra
Daly, Mary
John, Esther
Hopper, John L.
Cigler, Tessa
CANCER RESEARCH, 2015, 75
[42] Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
K Metcalfe
S Gershman
H T Lynch
P Ghadirian
N Tung
C Kim-Sing
O I Olopade
S Domchek
J McLennan
A Eisen
W D Foulkes
B Rosen
P Sun
S A Narod
British Journal of Cancer, 2011, 104 : 1384 - 1392
[43] Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
Timothy R Rebbeck
Susan M Domchek
Breast Cancer Research, 10
[44] Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Graeser, Monika K.
Engel, Christoph
Rhiem, Kerstin
Gadzicki, Dorothea
Bick, Ulrich
Kast, Karin
Froster, Ursula G.
Schlehe, Bettina
Bechtold, Astrid
Arnold, Norbert
Preisler-Adams, Sabine
Nestle-Kraemling, Carolin
Zaino, Mohammad
Loeffler, Markus
Kiechle, Marion
Meindl, Alfons
Varga, Dominic
Schmutzler, Rita K.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : 5887 - 5892
[45] Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
Metcalfe, K.
Gershman, S.
Lynch, H. T.
Ghadirian, P.
Tung, N.
Kim-Sing, C.
Olopade, O. I.
Domchek, S.
McLennan, J.
Eisen, A.
Foulkes, W. D.
Rosen, B.
Sun, P.
Narod, S. A.
BRITISH JOURNAL OF CANCER, 2011, 104 (09) : 1384 - 1392
[46] Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
Rebbeck, Timothy R.
Domchek, Susan M.
BREAST CANCER RESEARCH, 2008, 10 (04)
[47] Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
Kotsopoulos, Joanne
Lubinski, Jan
Salmena, Leonardo
Lynch, Henry T.
Kim-Sing, Charmaine
Foulkes, William D.
Ghadirian, Parviz
Neuhausen, Susan L.
Demsky, Rochelle
Tung, Nadine
Ainsworth, Peter
Senter, Leigha
Eisen, Andrea
Eng, Charis
Singer, Christian
Ginsburg, Ophira
Blum, Joanne
Huzarski, Tomasz
Poll, Aletta
Sun, Ping
Narod, Steven A.
BREAST CANCER RESEARCH, 2012, 14 (02):
[48] Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
Ahmed, M.
Lalloo, F.
Howell, A.
Evans, D. G.
BREAST CANCER RESEARCH, 2010, 12 : S6 - S6
[49] Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers
Metcalfe, Kelly
Lynch, Henry T.
Ghadirian, Parviz
Tung, Nadine
Kim-Sing, Charmaine
Olopade, Olufunmilayo I.
Domchek, Susan
Eisen, Andrea
Foulkes, William D.
Rosen, Barry
Vesprini, Danny
Sun, Ping
Narod, Steven A.
BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (01) : 287 - 296
[50] Comparison of Nodal Metastasis Between BRCA Mutation Carriers and Non-BRCA Mutation Carriers with Breast Cancer
Shahrbanoo F. Noori
Alexandra Gangi
Maria E. Nelson
Michael Choi
Parisa Mirzadehgan
Alison K. Bonk
James Mirocha
Farin Amersi
Armando E. Giuliano
Annals of Surgical Oncology, 2014, 21 : 3324 - 3329

← 1 2 3 4 5 →